Abstract

Circadian clocks coordinate mammalian behavior and physiology enabling organisms to anticipate 24-hour cycles. Transcription-translation feedback loops are thought to drive these clocks in most of mammalian cells. However, red blood cells (RBCs), which do not contain a nucleus, and cannot perform transcription or translation, nonetheless exhibit circadian redox rhythms. Here we show human RBCs display circadian regulation of glucose metabolism, which is required to sustain daily redox oscillations. We found daily rhythms of metabolite levels and flux through glycolysis and the pentose phosphate pathway (PPP). We show that inhibition of critical enzymes in either pathway abolished 24-hour rhythms in metabolic flux and redox oscillations, and determined that metabolic oscillations are necessary for redox rhythmicity. Furthermore, metabolic flux rhythms also occur in nucleated cells, and persist when the core transcriptional circadian clockwork is absent in Bmal1 knockouts. Thus, we propose that rhythmic glucose metabolism is an integral process in circadian rhythms.

Red blood cells, which do not possess a nucleus, have circadian redox rhythms with incompletely understood regulatory mechanisms. Here the authors show that glucose metabolism plays a crucial role in regulating circadian redox status of human red blood cells.

Details

Title
Rhythmic glucose metabolism regulates the redox circadian clockwork in human red blood cells
Author
Ratnasekhar, Ch 1   VIAFID ORCID Logo  ; Rey Guillaume 2   VIAFID ORCID Logo  ; Ray Sandipan 3 ; Jha, Pawan K 4 ; Driscoll, Paul C 5   VIAFID ORCID Logo  ; Dos Santos Mariana Silva 5   VIAFID ORCID Logo  ; Malik, Dania M 4 ; Lach Radoslaw 6 ; Weljie, Aalim M 4 ; MacRae, James I 5   VIAFID ORCID Logo  ; Valekunja, Utham K 4   VIAFID ORCID Logo  ; Reddy, Akhilesh B 7 

 University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK (GRID:grid.470900.a) (ISNI:0000 0004 0369 9638); Queen’s University Belfast, School of Biological Sciences, Belfast, UK (GRID:grid.4777.3) (ISNI:0000 0004 0374 7521) 
 University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK (GRID:grid.470900.a) (ISNI:0000 0004 0369 9638); Unilabs Genetics Laboratory, Lausanne, Switzerland (GRID:grid.470900.a) 
 University of Pennsylvania, Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, Pennsylvania, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972); University of Pennsylvania, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972); Indian Institute of Technology Hyderabad, Department of Biotechnology, Kandi, Sangareddy, India (GRID:grid.459612.d) (ISNI:0000 0004 1767 065X) 
 University of Pennsylvania, Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, Pennsylvania, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972); University of Pennsylvania, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972) 
 The Francis Crick Institute, London, UK (GRID:grid.451388.3) (ISNI:0000 0004 1795 1830) 
 University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK (GRID:grid.470900.a) (ISNI:0000 0004 0369 9638); University of Cambridge, Department of Oncology, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934) 
 University of Pennsylvania, Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, Pennsylvania, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972); University of Pennsylvania, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972); University of Pennsylvania Perelman School of Medicine, Institute for Diabetes, Obesity, and Metabolism, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972); University of Pennsylvania, Chronobiology and Sleep institute (CSI), Perelman School of Medicine, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2478165812
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.